Compound discovered in aloe vera with potential for developing drugs against Alzheimer's
Beta-sitosterol showed binding affinity with enzymes associated with Alzheimer's. Photo: iStock
TL;DR
- A study identified beta-sitosterol, a compound in aloe vera, as having potential for Alzheimer's drug development.
- Beta-sitosterol showed significant binding affinity and stability with AChE and BChE enzymes.
- These enzymes are involved in the breakdown of acetylcholine, a neurotransmitter crucial for memory, which is reduced in Alzheimer's patients.
- Current treatments aim to inhibit these enzymes to increase acetylcholine availability.
- The findings are preliminary, requiring further research to determine efficacy, safety, and viability for clinical use.